Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice

Hironori Adachi, Tatsuya Kondo, Gou Young Koh, Andras Nagy, Yuichi Oike, Eiichi Araki

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Angiopoietin-like protein family 4 (Angptl4) has been shown to regulate lipoprotein metabolism through the inhibition of lipoprotein lipase (LPL). In familial hypercholesterolemia (FH), individuals lacking low-density lipoprotein receptor (LDLR) present not only hypercholesterolemia, but also increased plasma triglyceride (TG)-rich lipoprotein remnants, and develop atherosclerosis. In addition, the most common type of dyslipidemia in individuals with diabetes is increased TG levels.We first generated LDLR-/-Angptl4-/- mice to study the effect of Angptl4 deficiency on the lipid metabolism. Fasting total cholesterol, VLDL-C, LDL-C, HDL-C and TG levels were decreased in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. In particular, post olive oil-loaded TG excursion were largely attenuated in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. We next introduced diabetes by streptozotocin (STZ) treatment in Angptl4-/- mice and examined the impacts of Angptl4 deficiency. Compared with diabetic Angptl4+/+ mice, diabetic Angptl4-/- mice showed the improvement of fasting and postprandial hypertriglyceridemia as well. Thus, targeted silencing of Angptl4 offers a potential therapeutic strategy for the treatment of dyslipidemia in individuals with FH and insulin deficient diabetes.

Original languageEnglish
Pages (from-to)177-180
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume409
Issue number2
DOIs
Publication statusPublished - 3 Jun 2011
Externally publishedYes

Keywords

  • Angptl4
  • Diabetes mellitus
  • Familial hypercholesterolemia
  • Lipoprotein lipase
  • Postprandial hypertriglyceridemia

Cite this

@article{b4abaa7bc9444e68be566f0c9b40fa3f,
title = "Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice",
abstract = "Angiopoietin-like protein family 4 (Angptl4) has been shown to regulate lipoprotein metabolism through the inhibition of lipoprotein lipase (LPL). In familial hypercholesterolemia (FH), individuals lacking low-density lipoprotein receptor (LDLR) present not only hypercholesterolemia, but also increased plasma triglyceride (TG)-rich lipoprotein remnants, and develop atherosclerosis. In addition, the most common type of dyslipidemia in individuals with diabetes is increased TG levels.We first generated LDLR-/-Angptl4-/- mice to study the effect of Angptl4 deficiency on the lipid metabolism. Fasting total cholesterol, VLDL-C, LDL-C, HDL-C and TG levels were decreased in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. In particular, post olive oil-loaded TG excursion were largely attenuated in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. We next introduced diabetes by streptozotocin (STZ) treatment in Angptl4-/- mice and examined the impacts of Angptl4 deficiency. Compared with diabetic Angptl4+/+ mice, diabetic Angptl4-/- mice showed the improvement of fasting and postprandial hypertriglyceridemia as well. Thus, targeted silencing of Angptl4 offers a potential therapeutic strategy for the treatment of dyslipidemia in individuals with FH and insulin deficient diabetes.",
keywords = "Angptl4, Diabetes mellitus, Familial hypercholesterolemia, Lipoprotein lipase, Postprandial hypertriglyceridemia",
author = "Hironori Adachi and Tatsuya Kondo and Koh, {Gou Young} and Andras Nagy and Yuichi Oike and Eiichi Araki",
year = "2011",
month = "6",
day = "3",
doi = "10.1016/j.bbrc.2011.04.110",
language = "English",
volume = "409",
pages = "177--180",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier",
number = "2",

}

Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice. / Adachi, Hironori; Kondo, Tatsuya; Koh, Gou Young; Nagy, Andras; Oike, Yuichi; Araki, Eiichi.

In: Biochemical and Biophysical Research Communications, Vol. 409, No. 2, 03.06.2011, p. 177-180.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Angptl4 deficiency decreases serum triglyceride levels in low-density lipoprotein receptor knockout mice and streptozotocin-induced diabetic mice

AU - Adachi, Hironori

AU - Kondo, Tatsuya

AU - Koh, Gou Young

AU - Nagy, Andras

AU - Oike, Yuichi

AU - Araki, Eiichi

PY - 2011/6/3

Y1 - 2011/6/3

N2 - Angiopoietin-like protein family 4 (Angptl4) has been shown to regulate lipoprotein metabolism through the inhibition of lipoprotein lipase (LPL). In familial hypercholesterolemia (FH), individuals lacking low-density lipoprotein receptor (LDLR) present not only hypercholesterolemia, but also increased plasma triglyceride (TG)-rich lipoprotein remnants, and develop atherosclerosis. In addition, the most common type of dyslipidemia in individuals with diabetes is increased TG levels.We first generated LDLR-/-Angptl4-/- mice to study the effect of Angptl4 deficiency on the lipid metabolism. Fasting total cholesterol, VLDL-C, LDL-C, HDL-C and TG levels were decreased in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. In particular, post olive oil-loaded TG excursion were largely attenuated in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. We next introduced diabetes by streptozotocin (STZ) treatment in Angptl4-/- mice and examined the impacts of Angptl4 deficiency. Compared with diabetic Angptl4+/+ mice, diabetic Angptl4-/- mice showed the improvement of fasting and postprandial hypertriglyceridemia as well. Thus, targeted silencing of Angptl4 offers a potential therapeutic strategy for the treatment of dyslipidemia in individuals with FH and insulin deficient diabetes.

AB - Angiopoietin-like protein family 4 (Angptl4) has been shown to regulate lipoprotein metabolism through the inhibition of lipoprotein lipase (LPL). In familial hypercholesterolemia (FH), individuals lacking low-density lipoprotein receptor (LDLR) present not only hypercholesterolemia, but also increased plasma triglyceride (TG)-rich lipoprotein remnants, and develop atherosclerosis. In addition, the most common type of dyslipidemia in individuals with diabetes is increased TG levels.We first generated LDLR-/-Angptl4-/- mice to study the effect of Angptl4 deficiency on the lipid metabolism. Fasting total cholesterol, VLDL-C, LDL-C, HDL-C and TG levels were decreased in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. In particular, post olive oil-loaded TG excursion were largely attenuated in LDLR-/-Angptl4-/- mice compared with LDLR-/-Angptl4+/+ mice. We next introduced diabetes by streptozotocin (STZ) treatment in Angptl4-/- mice and examined the impacts of Angptl4 deficiency. Compared with diabetic Angptl4+/+ mice, diabetic Angptl4-/- mice showed the improvement of fasting and postprandial hypertriglyceridemia as well. Thus, targeted silencing of Angptl4 offers a potential therapeutic strategy for the treatment of dyslipidemia in individuals with FH and insulin deficient diabetes.

KW - Angptl4

KW - Diabetes mellitus

KW - Familial hypercholesterolemia

KW - Lipoprotein lipase

KW - Postprandial hypertriglyceridemia

UR - http://www.scopus.com/inward/record.url?scp=79957895547&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.04.110

DO - 10.1016/j.bbrc.2011.04.110

M3 - Article

VL - 409

SP - 177

EP - 180

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -